Establishment of cell-based transposon-mediated transgenesis in cattle by Alessio, Ana Paula et al.
Accepted Manuscript
Establishment of cell-based transposon-mediated transgenesis in cattle
Ana P. Alessio, Alejandro E. Fili, Wiebke Garrels, Diego O. Forcato, María F.
Olmos Nicotra, Ana C. Liaudat, Romina J. Bevacqua, Virginia Savy, María I. Hiriart,
Thirumala R. Talluri, Jesse B. Owens, Zoltán Ivics, Daniel F. Salamone, Stefan




To appear in: Theriogenology
Received Date: 30 October 2015
Revised Date: 10 December 2015
Accepted Date: 18 December 2015
Please cite this article as: Alessio AP, Fili AE, Garrels W, Forcato DO, Olmos Nicotra MF, Liaudat AC,
Bevacqua RJ, Savy V, Hiriart MI, Talluri TR, Owens JB, Ivics Z, Salamone DF, Moisyadi S, Kues WA,
Bosch P, Establishment of cell-based transposon-mediated transgenesis in cattle, Theriogenology
(2016), doi: 10.1016/j.theriogenology.2015.12.016.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
















Establishment of cell-based transposon-mediated transgenesis in cattle 2 
Ana P. Alessio1,*, Alejandro E. Fili1,*, Wiebke Garrels2,3, Diego O. Forcato1, María F. Olmos 3 
Nicotra1, Ana C. Liaudat1, Romina J. Bevacqua4, Virginia Savy4, María I. Hiriart4, Thirumala R. 4 
Talluri2,5, Jesse B. Owens6, Zoltán Ivics7, Daniel F. Salamone4, Stefan Moisyadi6, Wilfried A. 5 
Kues2 and Pablo Bosch1 6 
* Equally contributing authors 7 
1 Departamento de Biología Molecular, Facultad de Ciencias Exactas, Fco-Qcas y Naturales, 8 
Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba, República Argentina 9 
2 Friedrich-Loeffler-Institut, Institut für Nutztiergenetik, Neustadt, Germany 10 
4 Laboratorio de Biotecnología Animal, Facultad de gronomía, Universidad de Buenos Aires, 11 
República Argentina 12 
6 Institute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology, John 13 
A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii 14 
7 Paul-Ehrlich-Institute, Division of Medical Biotechnology, Langen, Germany 15 
Current address: 16 
3 Hannover Medical School, University of Hannover, Hannover, Germany 17 
5 National Research Centre on Equines, Bikaner, India 18 
Corresponding author: 19 
Pablo Bosch 20 
E-mail:  pbosch@exa.unrc.edu.ar 21 
Telephone: +54-0358-4676425 Ext. 3 22 
Fax: +54-0358-4676232 23 
Key words: cattle, transgenesis, transposon, Sleeping Beauty, piggyBac 24 
















Transposon-mediated transgenesis is a well-established tool for genome modification in small 2 
animal models. However, translation of this active transgenic method to large animals warrants 3 
further investigations. Here, the piggyBac (PB) and Sleeping Beauty (SB) transposon systems 4 
were assessed for stable gene transfer into the cattle genome. Bovine fibroblasts were transfected 5 
either with a helper-independent PB system or a binary SB system. Both transposons were highly 6 
active in bovine cells increasing the efficiency of DNA integration up to 88 times over basal 7 
non-facilitated integrations in a colony formation assay. SB transposase catalyzed multiplex 8 
transgene integrations in fibroblast cells transfected with the helper vector and two donor vectors 9 
carrying different transgenes (fluorophore and neomycin resistance). Stably transfected 10 
fibroblasts were employed for somatic cell nuclear transfer (SCNT) and upon in vitro embryo 11 
culture, morphologically normal blastocysts that expressed the fluorophore were obtained with 12 
both transposon systems. The data indicate that transposition is a feasible approach for genetic 13 















1. Introduction 1 
The advent of high throughput DNA sequencing methods and comprehensive annotated genome 2 
maps concomitantly with advanced active transgenic techniques promise to revolutionize the 3 
field of animal biotechnology. In particular, areas like disease modeling, biopharming, as well as 4 
basic research will benefit enormously by introducing precise genetic engineering tools to 5 
manipulate livestock genomes. Initial transgenic methods relayed on passive (non-facilitated) 6 
genomic integration of transgenes at sites of spontaneously arising double-strand breaks (DSBs) 7 
of chromosomes after direct injection of naked DNA into zygotes (pronuclear injection) or 8 
transfection of cultured cells followed by somatic cell nuclear transfer (SCNT). Homologous 9 
recombination in somatic cells of livestock is an extremely rare event, and only a few genes were 10 
targeted in recent years [1-7]. These inefficient and unreproducible approaches were gradually 11 
superseded by a new generation of active methods in which genomic insertion of heterologous 12 
DNA molecules is catalyzed by exogenously provided enzymes that catalyze DNA 13 
recombination [Reviewed in 8, 9]. 14 
For gain-of-function approaches in farm animals, the engineered transposon systems Sleeping 15 
Beauty (SB) and piggyBac (PB) gained increasing interests in recent years [10, 11]. Transposon-16 
based transgenic methods, derived from naturally occurring DNA transposable elements, are 17 
non-viral gene delivery systems capable of efficient enzyme-mediated genomic insertion of 18 
DNA segments into the genome. During transposition a single-copy of the sequence of interest 19 
framed by inverted terminal repeats (ITRs) is integrated into the genome through a precise, 20 
transposase-catalyzed mechanism, providing long-term expression of the gene of interest in cells 21 
[12]. Bi-component transposon-based transgenic systems comprise a donor vector containing the 22 















mRNA or most commonly as a helper DNA vector. In addition, systems that combine both 1 
components in a single vector, known as helper-independent transposons, have been developed 2 
and validated in cells and animals [13-16]. Transposase catalyzes both the excision of the 3 
transgene from the donor vector and its integration into a genomic target site. Integration occurs 4 
at short consensus sequences, for example Tc1/mariner transposases, like SB, recognize TA 5 
dinucleotides [17], and PB transposase recognizes TTAA tetranucleotides [18]. Through this 6 
mechanism one monomeric copy of a transposon is integrated in the genome, leaving the empty 7 
backbone of the donor plasmid, which is eventually degraded [12, 19, 20] or, rarely, randomly 8 
integrated [14, 21]. Expression units introduced by transposition are less prone to epigenetic 9 
silencing, and show long-term expression of the transgene [12], suggesting that transposons have 10 
a tendency to land in genomic regions that are transcriptionally permissive [22]. 11 
PB and SB transposons have been extensively studied for transgenesis in mice, rats and rabbits 12 
[13, 23-26]. Both in vivo (intracytoplasmic injection of zygotes) and in vitro (somatic cell 13 
nuclear transfer, SCNT) approaches have been exploited in order to generate transposon-14 
transgenic pig models [12, 20, 27-31]. Zygote microinjection with SB transposon components 15 
has resulted in single-copy integration units into the pig preimplantation embryo genome [20], 16 
into born F0 animals and successful transmission to F1 generation [12]. Garrels et al. [12] 17 
demonstrated segregation of individual transposons in the F1 offspring, copy-number dependent 18 
expression of reporter protein over a prolonged time with no evidence of gene silencing. 19 
Similarly, transgenic pigs generated by microinjection of a helper-independent, self-inactivating 20 
PB transposon had monogenic and often single transgene genomic integration and absence of 21 
concatemers or variegated transgene expression [28]. 22 
Alternatively, genetic modification of somatic cells by PB or SB transposition followed by 23 















and SB transposon systems for the genetic modification of bovine fibroblasts, which were 1 
subsequently employed in SCNT. 2 
To this end, cultured fibroblast cells were transfected or electroporated with both transposon 3 
systems, respectively, and upon selection or enrichment of transgenic cells, they were used as 4 
nuclear donor in SCNT. The use of transposons is associated with enhanced proportion of stably 5 
transfected cells, as it has been documented for established immortalized and primary porcine 6 
cells [32] transfected with SB, PB, Tol2 or Passport transposon systems [20, 32] as well as for 7 
primary bovine fibroblasts transfected with PB [33]. These promising results warrant more 8 
research that extends and adapts transposon-based methods to functional transgene products and 9 
to economically important livestock species such as cattle. 10 
2. Materials and Methods 11 
2.1. Experimental Design 12 
The experimental design is summarized in the Fig. 1. Fibroblast cultures were established from 13 
fetuses collected at a local abattoir. Fibroblasts were transfected with either SB transposon 14 
components or PB helper-independent plasmids followed by a 3-week antibiotic selection 15 
period. The number of resistant colonies was counted and representative colonies were picked 16 
and expanded to obtain genomic DNA (gDNA) for molecular analysis of transposon genomic 17 
integration (PCR, nrLAM-PCR and Splinkerette PCR). Transgenic polyclonal cell cultures 18 
generated from PB or SB were used as nuclear donors in SCNT experiments in order to assess 19 















2.2. Vectors 1 
2.2.1. PiggyBac plasmids: 2 
The experiments were carried out using pmGENIE-3-based plasmids. pmGENIE-3 combines in a 3 
single plasmid the transposon and the transposase coding sequence (helper-independent system). 4 
Another feature of this plasmid is that a portion of the transposase coding sequence is deleted 5 
upon transposition (self-inactivation) [14]. 6 
pmGENIE-3: this plasmid carries EGFP coding sequence which is under of control of CAG 7 
promoter. In addition the plasmid harbors the hygromycin B resistance gene. 8 
pmhyGENIE-3: differs from pmGENIE-3 in that it contains a sequence that codes a hyperactive 9 
version of the PB transposase. 10 
pmGENIE-2/∆ piggyBac: it is a control plasmid that codes for a non-functional truncated 11 
transposase. We will refer to this plasmid as pmGENIE-Control. 12 
pmhyGENIE-3, pmGENIE-3 and pmGENIE-Control were previously described [14]. 13 
2.2.2. Sleeping Beauty plasmids: 14 
pCMV(CAT)T7-SB100X: this plasmid contains an eukaryotic expression cassette for SB 15 
transposase under the control of CMV promoter. The SB transposase expressed by this construct 16 
is an optimized version (SB100X) with enhanced transposition activity [10]. 17 
pT2RMCEVenus: this plasmid contains an eukaryotic expression cassette for Venus fluorescent 18 
protein under the control of CAGGS promoter. The expression cassette is flanked by 5`and 3´ 19 
ITRs of SB transposon. 20 
pT2/SV40-Neo: this plasmid contains an expression cassette for neomycin phosphotransferase, 21 
which confers resistance to the antibiotic geneticin (G418), flanked by SB ITRs. SV40 promoter 22 















pBSII-ISceI-skA: this plasmid is used as control in experiments with SB system (kindly provided 1 
by Dr. Jochen Wittbrodt, Developmental Biology Programme, EMBL-Heidelberg, Heidelberg, 2 
Germany). 3 
Schematic representations of all plasmids are depicted in Fig. 2. 4 
2.3. Culture of primary cells 5 
Primary bovine fetal fibroblasts (BFF) were obtained from slaughterhouse fetuses of 90-150 6 
days of gestation. Fetuses were transported to the laboratory where they were processed in a 7 
laminar-flow cabinet. A piece of subdermal tissue (about 1 cm2) was removed from the flank of 8 
the fetus and sectioned with a scalpel blade into smaller pieces. Explants were placed in cell 9 
culture plates (3 to 4 explants per 100 mm plate) in 6 ml of cell culture medium (DMEM, 1x 10 
antibiotic / antimycotic, Gibco, CA, USA) supplemented with 10% FBS (Natocor, Cordoba, 11 
Rep. Argentina) and cultured for approximately 10 days in an atmosphere of 5% CO2 in air and 12 
high humidity at 38.5ºC. When the cells reached 70-80% confluence, they were trypsinized 13 
(trypsin 0.5%, Sigma-Aldrich Co., St. Louis, MO, USA) and passaged to a T-75 culture flask for 14 
cell propagation. Fibroblasts were frozen in DMEM containing 20% FBS and 10% DMSO 15 
(Sigma-Aldrich Co., St. Louis, MO, USA) and kept in liquid nitrogen until use. 16 
2.4. Cell transfection with transposon vectors 17 
Bovine fetal fibroblasts were seeded at 0.5x105 cells per well of a 24-well plate. When the cells 18 
reached 80% confluence (12-24 h), cultures were transfected with a polyethylenimine-based 19 
transfection reagent (JetPRIME®, Polyplus-transfection SA, Illkirch, France) and 1 µg of 20 
plasmid DNA according to the manufacturer’s instructions. Forty eight hours post-transfection, 21 
expression of reporter fluorescent protein was assessed in a microscope equipped with 22 















transfected cells were captured with a Nikon DS-Qi1Mc camera using the same acquisition 1 
settings for all pictures taken. Subsequently, cells from each well were trypsinized and 2 
transferred into a 100-mm culture plate with 8 ml DMEM supplemented with 10% FBS and 3 
selected for 14 days with the appropriate antibiotic, depending on the particular plasmid used 4 
(pmGENIE-3: hygromycin B; SB system: G418). 5 
For piggyBac system, fibroblasts were transfected with pmGENIE-3-based plasmids 6 
(pmhyGENIE-3, pmGENIE-3 or pmGENIE-Control) followed by 14-day selection with 50 7 
µg/ml hygromycin B (Invitrogen, Van Allen Way Carlsbad, California, USA). The media was 8 
replaced every other day. 9 
In the first SB transfection experiment, fibroblast cultures were co-transfected with 10 
pT2RMCEVenus (donor plasmid) and pCMV(CAT)T7-SB100X (helper plasmid). In the second 11 
experiment, fibroblasts were co-transfected with pT2RMCEVenus, pT2/SV40-Neo and 12 
pCMV(CAT)T7-SB100X. In both experiments, we included a treatment in which the 13 
pCMV(CAT)T7-SB100X was replaced by the same amount of pBSII-ISceI-skA which lacks a 14 
SB transposase as a negative control, thus background, (non-facilitated) transgene integration 15 
could be estimated. No antibiotic selection was applied for cells transfected with 16 
pT2RMCEVenus since this vector is devoid of antibiotic selection cassette and the number of 17 
fluorescent colonies was determined 12-14 days post transfection. In experiments of co-18 
transfection in which pT2/SV40-Neo was included, G418 selection (250 µg/ml; Invitrogen, Van 19 
Allen Way Carlsbad, California, USA) was implemented for two weeks with media replacement 20 















2.5. Colony formation assay and derivation of monoclonal transgenic cell lines 1 
Transfected cells were kept under antibiotic selection for two weeks and the numbers of 2 
fluorescent colonies were counted in an inverted microscope (Nikon Corp., Tokyo, Japan) with 3 
epifluorescence equipment. To assess the transposition activity of the different plasmids we 4 
calculated the relative fold change, which was obtained by dividing the number of antibiotic 5 
resistant colonies counted in cultures transfected with pmhyGENIE-3 or pmGENIE-3 plasmids 6 
by the number of colonies in those transfected with pmGENIE-Control plasmid. 7 
In the SB experiment in which fibroblasts were co-transfected with two plasmids 8 
(pT2RMCEVenus and pCMV(CAT)T7-SB100X), the number of Venus positive colonies 9 
formed after two-week culture were compared with those in the control treatment. When cell 10 
cultures were co-transfected with three plasmids (pT2RMCEVenus, pT2/SV40-Neo and 11 
pCMV(CAT)T7-SB100X), the number of colonies originated under antibiotic selection (G418) 12 
were determined after 14 days. 13 
For clonal expansion, individual cell colonies were recovered from 100 mm plates using cloning 14 
rings, small plastic cylinders of 7 mm of diameter that were placed over each individual colony 15 
and fixed and sealed with agarose [35]. Cells inside the cloning ring were trypsinized and 16 
cultivated in 24-well-plates up to 80-90% confluence. Cell lines were sequentially passaged into 17 
larger-sized culture plates as the number of cells increased. Once they reached 80-90% of 18 
confluence in a T75 culture flask each cell line was processed to obtain gDNA for molecular 19 
characterization of transgene integration. 20 
2.6. Molecular characterization of transgene genomic integrations 21 
PCR: Genomic DNA was isolated from transgenic cell lines using Quick-gDNA™ MiniPrep 22 















designed a PCR strategy (four reactions) to characterize PB transgene genomic integrations 1 
(non-facilitated or transposase catalyzed). PCR1: amplification of a 187-bp fragment of the 2 
EGFP gene with primers pair PB-GFP-F/ PB-GFP-R. Presence of a correct-size PCR product 3 
confirmed the presence of the transgene (Fig. 3 g). PCR2: amplified a 537- bp fragment 4 
extending from the 3’-ITR into the backbone of the plasmid using primers pair PB-ITR-F/PB-5 
ITR-R. Amplification of the correct size product would indicate non-transpositional transgene 6 
integration (Fig. 3 g). PCR3: this reaction was included to determinate if nontranspositional 7 
integration of the recircularized backbone of the plasmid after transposition had occurred, as it 8 
was reported in mice [14]. PCR was performed using PB-RL-F/PB-RL-R primer pair to amplify 9 
a 442-pb backbone fragment (Fig. 5 a). Identity of PCR products was confirmed by sequencing. 10 
PCR4: To determinate integration of PB transposase sequences into the bovine genome primer 11 
pair PB-TPase-F /PB-TPase-R was used (Fig. 3 g). A PCR amplicon of 245 bp was expected in 12 
cell lines that contained at least one integrated copy of the PB transposase coding sequence. 13 
Multiplex PCRs were run using the following parameters: initial denaturalization at 94°C for 9 14 
min followed by 30 cycles of 20 s denaturalization at 94°C, 30 s annealing at 60°C, and 30 s 15 
elongation at 72°C, with a final elongation of 5 min. 16 
gDNA isolated from six SB monoclonal transgenic cell lines was used as template in a series of 17 
four reactions of PCRs to characterize SB transgene integrations . PCR1: amplification of a 280-18 
bp fragment from the Venus gene with primers pair SB-Venus-F/ SB-Venus-R (Fig. 7 e). 19 
Presence of a correct-size PCR product confirmed the presence of the transgene. PCR2: 20 
amplification of a 408-bp fragment extending from the 3’-ITR into the backbone of the plasmid 21 
using primers pair SB-ITR-F/SB-ITR-R (Fig. 7 e). Amplification of the correct size product 22 
indicated non-transpositional transgene integration. PCR3: amplification of a 493-bp fragment of 23 















product indicated genomic integration of backbone sequences by non-transpositional 1 
mechanisms. PCR4: this reaction was conducted with primer pair SB-RL-F/SB-RL-R (Fig. 5 a). 2 
Presence of a 233-bp amplicon indicated genomic integration of re-ligated backbone after 3 
transposition had occurred. PCR product was identified by restriction enzyme digestion (XhoI). 4 
Upon digestion, the expected product would render two fragments of 75 bp and 158 bp. PCR5: 5 
this reaction was run with primer pair SB-TPase-F/SB-TPase-R (Fig. 7 e). Presence of a 643 bp 6 
fragment indicated genomic non-facilitated insertion of the helper SBX100 plasmid. 7 
All PCRs were run with the following parameters: initial denaturalization at 95°C for 5 min 8 
followed by 35 cycles of 15 s denaturalization at 95°C, 15 s annealing at 63°C, and 45 s 9 
elongation at 72°C, with a final elongation of 10 min. 10 
All primer sequences are shown in Supplementary Table 1. 11 
2.7. Real-time quantitative PCR 12 
Number of EGFP copies per clonal cell line (n=9) was determined by real-time PCR as described 13 
previously by Lee et al. [36]. Briefly, 20 ng of genomic DNA was used as template in real-time 14 
qPCR using KAPA SYBR® FAST qPCR kit (Kapa Biosystem Inc., Boston, MA, USA) and 15 
Applied Biosystems 7500 instrument (Applied Biosystems, Waltham, MA USA). Primer set 16 
used to amplify EGFP transgene was PB-GFP-F - PB-GFP-R (Supplementary Table 1). qPCR 17 
was run using the following parameters: initial denaturalization at 94°C for 10 min followed by 18 
40 cycles of 10 s denaturalization at 95°C, 10 s annealing at 61°C and 10 s elongation at 72°C. 19 
The fluorescent signal was measured at the end of each elongation step at 72°C. After 20 
amplification, a melting curve was performed by increasing the temperature from 70 to 95°C at a 21 















standard curve which was generated using 10-fold serial dilution pmGENIE-3 (5.93 × 102 to 5.93 1 
× 106 copies/µl). 2 
2.8. Measurement of cell line fluorescence intensity 3 
To establish a putative association between transgene copy number and fluorescence intensity of 4 
transgenic cell lines (n=9), we measured fluorescence in individual cells using ImageJ software 5 
(V1.49, NHI) and CTCF using the following equation: CTCF = Integrated Density – (Area of 6 
selected cell x mean fluorescence of background readings) as previously described [37]. Linear 7 
regression analysis was performed using CTCF as independent variable and transgene copy 8 
number as dependent variable. 9 
2.9. Nonrestrictive Linear Amplification-Mediated PCR (nrLAM-PCR) 10 
Identification of transpositionally generated sites of insertion was achieved by nrLAM-PCR 11 
according to published protocols [38, 39]. Genomic DNA from pmGENIE-3 transgenic cell lines 12 
was used as a template for linear amplification and nested PCR was implemented to amplify the 13 
sequence flanking the PB insertions. PCR products were cloned into a vector and sequenced. 14 
DNA sequences directly flanking the transposon were mapped to the bovine genome by doing a 15 
BLAST search at the NCBI website (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 16 
2.10. Splinkerette PCR 17 
SB insertions in six Venus+/NeoR monoclonal cell lines were characterized by a splinkerette 18 
PCR method as previously described [40]. Transgene flanking sequences were used to map 19 















2.11. Somatic cell nuclear transfer 1 
Oocyte collection and in vitro maturation: Bovine ovaries were collected from abattoirs and 2 
transported to the laboratory at 25 °C to 30 °C. Cumulus-oocyte complexes were aspirated with 3 
21-gauge needles from follicles with a diameter of 2 to 5 mm into HEPES-buffered Tyrode's 4 
albumin lactate pyruvate (HEPES-TALP). Oocytes covered with at least three layers of 5 
granulosa cells were selected for IVM. The maturation medium was bicarbonate-buffered TCM-6 
199 (31100-035; Gibco, Grand Island, NY, USA), containing 10% fetal bovine serum (013/07; 7 
Internegocios, Buenos Aires, Argentina), 10 µg/mL follicle stimulating hormone (NIH-FSH-P1; 8 
Folltropin; Bioniche, Caufield North, Victoria, Australia), 0.3 mM sodium pyruvate (Sigma, 9 
P2256), 100 µM cysteamine (Sigma, M9768), and 2% antibiotic-antimycotic (15240-096; 10 
Gibco). The oocytes were incubated for 21 hours in 100 µL droplets under mineral oil (Sigma, 11 
M8410), in 6.5% CO2 in humidified air at 39 °C. 12 
Enucleation procedure: After 21 h of IVM, MII oocytes were subjected to hyaluronidase 13 
treatment followed by incubation in 1.5 mg/ml pronase to remove the Zona pellucida. Zona-free 14 
oocytes were stained with 1 µg/mL of Hoechst 33342 for 10 min. and afterwards transferred into 15 
50 µL microdroplets of HEPES-TALP supplemented with 0.3 g/mL BSA, under mineral oil, in 16 
100 × 20 mm tissue culture dishes (430167; Corning, Horseheads, NY, USA). The stained 17 
oocytes were mechanically enucleated using a Narishige hydraulic micromanipulator (Narishige 18 
Sci., Tokyo, Japan) mounted on a Nikon Eclipse E-300 microscope (Nikon, Tokyo, Japan). 19 
Enucleation was performed using a blunt 20 µm internal diameter pipette. Zona-free oocytes 20 
were supported for enucleation with a closed holding pipette (100-150 µm outer diameter, 21 
perpendicular break, closed fire-polished tip). Metaphase chromosomes were visualized under 22 















cytoplasm. Chromosome removal was confirmed by the presence of stained MII chromosomes 1 
inside the pipette. 2 
Donor cell preparation and fusion to enucleated oocytes: Cells transfected with pmhyGENIE-3 or 3 
SB plasmids, selected during 20 days, were used as donors for cloning. Briefly, the ZP-free 4 
enucleated oocytes were individually transferred to a drop of 1 mg/ml phytohemagglutinin 5 
(Sigma, L8754) dissolved in TCM-199 without serum, where they remained for a few seconds. 6 
Following this, they were quickly dropped over a single cell resting on the bottom of a 100 µl 7 
TALP-H drop. Following attachment, the ZP-free enucleated oocyte/cell pair was picked up, 8 
transferred to fusion medium (0.3 M mannitol, 0.1 mM MgSO4, 0.05 mM CaCl2, 1 mg/ml PVA), 9 
for 2–3 min and then to a fusion chamber (BTX Instrument Division; Harvard Apparatus, 10 
Holliston, MA, USA) containing 2 ml of the same warm medium. Fusion was performed with a 11 
double direct current (dc) pulse of 75 V, each pulse for 30 ms, 0.1 s apart. The reconstructed 12 
zygotes were then carefully transferred to SOF culture droplets for 2 h to allow for nuclear 13 
reprogramming. 14 
Chemical oocyte activation: Embryos produced by SCNT were activated with 5 µM ionomycin 15 
(I24222; Invitrogen, Van Allen Way Carlsbad, California, USA) in HEPES-TALP for 4 min and 16 
subsequently transferred individually to 1.9 mM DMAP (Sigma, D2629) in SOF droplets for 3 h. 17 
Embryos were then washed three times in HEPES-TALP to remove the inhibitor, and cultured as 18 
described below. 19 
In vitro embryo culture: Reconstructed SCNT embryos were cultured in SOF medium in a 20 
system similar to the Well of the Well (WOW) [41], whereby microwells were produced using a 21 
heated glass capillary slightly pressed to the bottom of a culture dish and then covered with a 100 22 
µl microdrop of SOF medium (20 to 30 WOW in each microdrop, 1 embryo per WOW). During 23 















7.5% FBS on day 5. Cleavage was evaluated on day 2, morula formation at day 5 and blastocyst 1 
formation on day 7 post-fusion. 2 
Evaluation of fluorophore expression in embryos: Cloned embryos were briefly exposed to blue 3 
light using specific excitation (460-498 nm) and an emission filters (510-540 nm) to determine 4 
EGFP or Venus expression on days 5 and 7 post-chemical activation. Images were captured with 5 
a Nikon DS-Qi1Mc camera using the same acquisition settings for all pictures taken. 6 
2.12. Embryo vitrification, thawing and cell counting 7 
Transgene expressing cloned blastocysts were vitrified as previously reported [42, 43]. Briefly, 8 
embryos were immersed sequentially in a series of glycerol and ethylene glycol solutions at 9 
room temperature (25 °C) as follows: 10% glycerol for 5 minutes followed by 10% glycerol + 10 
20% ethylene glycol for 5 min and finally 25% ethylene glycol + 25% glycerol for 30 sec. The 11 
embryos were aspirated into 1 µl tips and cryotubes immersed in liquid nitrogen. For 12 
devitrification, immediately after recovery of embryos from liquid nitrogen, they were placed for 13 
5 min in a solution of 12.5% ethylene glycol +12.5% glycerol + 0.5 M sucrose in PBS with 20% 14 
fetal bovine serum. Afterwards, they were placed in 0.5 M sucrose solution and 0.25 M sucrose 15 
solution (5 min in each solution). Finally, the embryos were washed 2 times in PBS 16 
supplemented with 1% serum. After thawing, embryos were placed back in SOFaa medium, and 17 
cell numbers of blastocysts that re-expanded were determined by staining with 1 µg/mL of 18 
Hoechst 33342 (B-2261; Sigma-Aldrich Co., St. Louis, MO, USA) for 10 min. Nuclei were 19 
visualized and counted using UV light in a microscope equipped with epifluorescence. 20 
2.13. Statistical analysis 21 
Number of colonies of each group was analyzed by ANOVA followed by Tukey´s test to 22 















letters in graph bars indicate statistically significant differences (p <0.05). All statistical analyses 1 
were performed with Statgraphics software (Statpoint Technologies, Inc. Warrenton, Virginia). 2 
3. Results 3 
3.1 Assessment of PB transposon activity in bovine fetal fibroblasts 4 
The experimental design is summarized in Fig. 1, and the employed plasmids are depicted in Fig. 5 
2. In order to assess the activity of PB transposase to mediated gene transfer into the bovine 6 
genome, BFFs were transfected with 1 µg of pmGENIE-3 or pmhyGENIE-3 (self-inactivating 7 
hyperactive piggyBac transposase-based plasmid). As control for random non-transpositional 8 
integration, BFFs were transfected in parallel with the control pmGENIE-2/∆piggyBac plasmid 9 
(Fig. 3, a-f). The mean number of hygromycin B-resistant colonies was markedly different 10 
among treatments (ANOVA, p˂0.0001; Fig. 4 a). In cell cultures transfected with PB constructs 11 
containing a functional sequence of PB transposase (i.e., pmGENIE-3 and pmhyGENIE-3) the 12 
number of resistant clones was higher compared with that in cultures transfected with the control 13 
plasmid in which only a few colonies developed (range 0-4 resistant colonies). More active at 14 
delivering DNA into the genome was the hyperactive version of the PB transposase, as 15 
pmhyGENIE-3-transfected group developed 3.24-times more colonies compared with that in the 16 
pmGENIE-3 group and 85-fold above of those in the pmGENIE-Control group (Fig. 4 a). 17 
3.2. Molecular characterization of transgene integration sites 18 
Molecular analyses by PCR were performed on gDNA isolated from a total of nine transgenic 19 
monoclonal cell lines. pmGENIE-3 and pmhyGENIE-3 plasmid DNA were used as positive 20 
controls. As expected, we obtained EGFP amplicons from all gDNA samples from pmGENIE-3 21 
transgenic group, demonstrating that analyzed cell lines carried the EGFP transgene (Fig. 3 g), 22 















template. Furthermore, no amplification product was obtained from gDNA isolated from six 1 
individual cell clones subjected to PCR to amplify a region extending from the 3’-ITR into the 2 
backbone of the plasmid (Fig. 3 g). These data supports a transposase-mediated transgene 3 
integration mechanism and absence of random, non-catalyzed whole plasmid integration events 4 
in six out of nine analyzed cell lines. In the remaining three transgenic cell lines (B2, B3 and B5; 5 
Fig 3 g), PCR products of the correct size were obtained in PCR2 and PCR3 what indicates 6 
random, non-facilitated genomic integration of full-length plasmids. Results from PCR4 revealed 7 
that one out of nine pmGENIE transgenic cell lines (A1) analyzed carried at least a religated 8 
plasmid backbone incorporated randomly into the genome (Fig. 5 b), but no evidence of full-9 
length plasmid insertion (Fig. 3 g). Religated plasmid backbone integration was confirmed by 10 
sequencing the 442 bp PCR product (Fig. 5 b). 11 
In order to identify the exact integration sites of the PB transposons in the bovine genome we 12 
performed a non-restrictive linear amplification-mediated PCR as described previously [38, 39]. 13 
Cloning and sequencing of seventeen integration sites from five monoclonal transgenic cell lines 14 
transfected with pmGENIE-3 confirmed specific transposase-mediated integration events at the 15 
PB TTAA tetranucleotide consensus sites. Fourteen out of the 17 analyzed integration sites could 16 
be assigned to specific positions in the bovine genome. Eleven of these were located in 17 
intergenic regions and three in intronic regions of genes (Supplementary Table 2). 18 
3.3. Transgene copy number and cell line fluorescence intensity 19 
The number of transgene copies per genome in pmGENIE-3 and pmhyGENIE-3 transgenic cell 20 
clones ranged from 1 to 13 copies. However, the majority of the cell lines carried 1 to 3 copies 21 















Phenotypic analysis of each PB transgenic cell line reveled different fluorescence intensity 1 
among cell lines with larger corrected total cell fluorescence (CTCF) values in those cell lines 2 
with a higher number of trangene copies per genome. Linear regression analysis demonstrated 3 
that fluorescence intensity is associated with transgene copy numbers (R2 = 0.93; p ˂0.05; Fig. 6 4 
b). 5 
3.4. Sleeping Beauty activity in bovine fetal fibroblasts 6 
Two separate experiments were conducted to study SB transposase activity in cultured BFF 7 
cells. In the first experiment BFFs were co-transfected by a chemical method (PEI-based 8 
transfection reagent) with different ratios of donor (the plasmid carrying the gene for Venus 9 
protein) and helper (SB100X) plasmids of the SB system. Presence of the transposase expression 10 
vector SBX100 in the transfection mixture boosted the number of colonies compared with those 11 
in the control treatment without transposase. We studied the effect of different weight ratios of 12 
helper to donor plasmid in the transfection reaction on the number of fluorescent colonies. When 13 
vectors were used at ratios of 1:1 and 2:1 (helper:donor), it caused a 78-fold and 88-fold increase 14 
in the number of colonies compared with that in the no transposase control and 1:2 ratio 15 
treatment respectively (p˂ 0.05; Fig. 4 b). 16 
Since the Venus vector lacks an antibiotic selection cassette, we designed an experiment to study 17 
SB transposition activity when two donor vectors are present. In this experiment, we co-18 
transfected BFFs with the helper vector plus two donor plasmids; one was carrying the gene for 19 
Venus protein and the other an antibiotic resistance gene (n o). After transfection, BFFs were 20 
cultured for 14 d in media containing G418 for resistant colony formation (Fig. 7, a, b, c and d). 21 
Regardless of the ratio used to transfect the BFF cultures, every time a functional SB transposase 22 















compared with that in the respective control without transposase (p˂ 0.001; Fig. 4 c). 1 
Interestingly, all G418 resistant colonies expressed the fluorescent protein. 2 
Selected SB transgenic colonies were propagated for gDNA isolation, PCR analysis and SCNT. 3 
3.5. Molecular characterization of SB transgene genomic integrations 4 
We designed five PCRs to characterize SB transposon integrations into the genomes of six 5 
monoclonal cell lines generated by cotransfection (ratio 2:0.5:0.5). As anticipated gDNA from 6 
all cell lines rendered an amplification product (280 bp) from Venus sequence (Fig. 7 f). To 7 
allow identification of putative non-transpositional genomic integration of the SB plasmid, we 8 
designed a PCR in which the forward primer hybridize in the 5´ITR and reverse primer on the 9 
vector backbone, therefore a product (408 bp) is generated if the complete plasmid is integrated 10 
by a non-facilitated mechanism. PCRs using gDNA from cell lines LM16, LM27, LM82 and 11 
LM87 generated a 408 bp product. Absence of a 408 bp product in gDNAs from lines LM25 and 12 
LM45 (Fig. 7 f) and concurrent amplification of Venus sequences from the same gDNA provides 13 
strong evidence for SB transposase-mediated transgene integration. None of the gDNA samples 14 
from transgenic cell lines generated a PCR product using the set of primers specific for the 15 
plasmid backbone (Fig. 7 e, f). We found no PCR evidence for genomic integration of SB helper 16 
plasmid (pCMV(CAT)T7-SB100X) in any SB transgenic cell lines studied. PCR analysis 17 
revealed that four out of six cell lines had at least one copy of the religated backbone plasmid 18 
inserted in their genomes (Fig. 5 c). Identity of PCR product was confirmed in by restriction 19 
enzyme digestion (Fig. 5 d). 20 
We have applied a splinkerette-PCR method to clone and analyze junctions of integrated SB 21 
transposons and the bovine genome. We identified 15 SB integrations that were mappable on the 22 















TA target site dinucleotide. Ten of these were located in intergenic regions and 5 in genes 1 
(Supplementary Table 3). 2 
3.6. Reprogramming transposon-transgenic cells by SCNT 3 
To test the ability of transposon transgenic cells to undergo nuclear reprograming to support 4 
early embryo development we performed SCNT with pmhyGENIE-3 or Venus+/G418-resistant 5 
transgenic polyclonal cell line. Development to blastocyst stage reached 33.0 and 36.0% for PB 6 
and SB transgenic cell lines respectively (Table 1; representative blastocysts are shown in Fig. 8 7 
a and b). Approximately half of the blastocyst homogenously expressed the reporter fluorophore 8 
protein (EGFP or Venus) at day 7 (Fig. 8 d and e). Autofluorescence was negligible in non-9 
transgenic blastocysts (Fig. 8 c and f). One out of three GFP expressing blastocysts from the 10 
pmhyGENIE group reexpanded upon thawing and culture; this blastocyst had 99 nuclei (Fig. 8 11 
g). Two out of four NT blastocysts generated with SB transgenic cells reexpanded after 12 
vitrification/devitrification procedure, and consisted of 176 (Fig. 8 h) and 81 nuclei, respectively. 13 
4. Discussion 14 
Transposons belong to a new generation of non-viral transgenic tools, known generically as 15 
active transgenesis methods, which have in common an enzyme-mediated mechanism of genome 16 
modification [8]. Being an enzymatic-based process, active transgenesis is more efficient and 17 
precise than traditional techniques in which transgenes are randomly integrated at natural 18 
occurring chromosomal DSBs and resolved by non-homologous end joining (NHEJ).  19 
In this study, we have implemented a transposon-mediated transgenic approach to introduce 20 
transgenes into the bovine genome. Both transposons, a helper-independent PB and a bi-21 















these genetically modified cells were amenable to nuclear reprogramming to drive development 1 
to morphologically normal blastocysts upon SCNT. 2 
It has been demonstrated that PB and SB transposases are functional in cells and embryos from 3 
different species including livestock [12, 20, 28, 30, 44-48]. Transgenic pigs carrying reporter 4 
genes introduced by transposition in cultured cells used for SCNT [20, 29] or one-cell embryos 5 
[12, 28] have been produced. Similarly, transposase-mediated transgene integration has been 6 
documented in ruminant cells [33, 44, 46, 49] and zygotes [50]. However, function and efficacy 7 
of PB and SB transposons in bovine cells and embryos has not been rigorously examined [51]. 8 
Initial experiments were designed to study if a PB helper-independent transgenic system already 9 
validated in different species [13, 28] and a bi-component SB transposon [10] could increase the 10 
efficiency of DNA integration into bovine fibroblast genome, the type of cell most commonly 11 
used as nuclear donor for SCNT. 12 
Transfection of cultured BFFs with pmGENIE-3 plasmids was associated with higher numbers 13 
of resistant cell colonies, indicating that the PB transposase facilitated genome integration of 14 
reporter and antibiotic resistance genes. Transfection of bovine cells with an upgraded version of 15 
pmGENIE-3 carrying a hyperactive variant of PB transposase [13] enhanced genome integration 16 
of reporter genes as indicated by approximately three-fold increase in colony formation over the 17 
conventional non-optimized enzyme and an unprecedented 85 times over those transfected with 18 
the control vector. High rates of transgene delivery have been achieved with both binary and 19 
single-plasmid PB transposon systems in cultured cells using classic colony formation assay 20 
[16]. pmGENIE-3 and its hyperactive version pmhyGENIE-3 were able to enhance HEK-293T 21 
colony formation seven and ten times respectively over those in the control without transposase 22 
[13]. Even higher transposition efficiency was observed in an established porcine cell line (28-23 















system [29]. Under our experimental conditions pmhyGENIE-3 was highly active in bovine cells 1 
being able to increment 85 times the number of resistant colonies compared with the control. 2 
With 324±17.8 resistant colonies obtained in pmhyGENIE-3 transfected cultures per 0.5x105 3 
plated fibroblasts, we can calculate a 21.6% of stably transfected cells based on ~3% of transient 4 
transfection efficiency. The observed higher gene transfer activity in bovine cells compared with 5 
that reported by others in pig [29] and sheep cells [44] may reflect species-specific cell 6 
characteristics or conditions that favor transgene transposition, such as presence or absence of 7 
cellular cofactors that affect transposase function, availability of DNA repair enzymes among 8 
others factors beyond intrinsic transposase activity. We also looked for non-enzymatic full-9 
length or vector backbone insertion into the host cell genome. We found PCR evidence for 10 
nontranspositional genomic insertions of full-length PB vectors in three out of nine cell lines 11 
analyzed and in four of six SB transgenic cell lines. In addition, recircularization of the remnant 12 
plasmid backbone after transposon excision followed by random genomic insertion has been 13 
documented for PB [14, 21] and SB transposon systems [52]. PCR analysis of gDNA from nine 14 
PB transgenic cell lines revealed that only one harbored plasmid backbone sequences in its 15 
genome, while four out of six SB transgenic cell lines had at least one copy of the religated 16 
plasmid backbone. These findings support the idea that besides degradation [53], chromosome 17 
integration is a potential fate for the plasmid backbone. 18 
To study the function of SB transposase in bovine cells, we co-transfected primary fibroblast 19 
cultures with the plasmids that comprises a binary SB system. Being a bi-component system, it 20 
seemed reasonable to optimize the amounts of helper to donor plasmids to achieve the desired 21 
transposition efficiency. Rations of 1:1 and 2:1 (helper:donor) resulted in 78 and 88 times more 22 
colonies respectively compared with the control. These results can be interpreted as SB 23 















vector in the transfection mixture it is possible to maximize transgene integration into the cell 1 
genome without apparent cell toxic effects. Interestingly, within the range of SB transposase 2 
studied in our experiment, the well-characterized overproduction inhibition phenomenon 3 
described for SB transposons [16, 54] was not observed. 4 
In the second SB experiment we use two donor plasmids, one carrying the Venus expression 5 
cassette and the other harboring a neo gene which confers resistance to G418. This design allows 6 
for selection of transgenic clonal cells lines using the neomycin analog G418. Results from this 7 
experiment confirmed the capacity of SB transposase to mediate incorporation of exogenous 8 
DNA into the bovine genome very efficiently. Surprisingly, all resistant colonies examined 9 
expressed the Venus protein what highlights the ability of SB transposase to simultaneously 10 
transpose two transgenes provided in separate donor plasmids. This multiplex feature could be of 11 
interest when the objective is to obtain bi-transgenic animals. In addition, independent genomic 12 
integration of the antibiotic selection cassette from the transgene of interest may be used to 13 
segregate the selectable marker by breeding [20] to generate transgenic animals devoid of 14 
antibiotic resistance sequences to comply with the recommendations of most regulatory 15 
agencies. 16 
Our nrLAM-PCR and splinkerette PCR data demonstrated that transgene integrations in the 17 
bovine genome corresponded with transposition-mediated events catalyzed by PB and SB 18 
transposase. All detected genomic integrations had on the right side the tetranucleotide TTAA 19 
for PB or TA dinucleotide for SB, followed by bovine genomic sequences, structures that agree 20 
with the known PB and SB transposition mechanisms [17, 55]. Transposition ensures single 21 
copy, independent genomic integrations of transgenes thus reducing markedly epigenetic 22 
problems, namely silencing and variegated transgene expression as observed with viral vectors 23 















number of PB and SB genomic integration sites (17 and 15, respectively) in the bovine genome 1 
does not allow us to make conclusive statements about the preferences of PB or SB transposase 2 
to direct transgenes to particular domains of the bovine genome. Analysis of 575 PB transposase-3 
mediated integration sites in the human genome showed that there is a slight tendency to 4 
incorporate the transposon into transcriptionally active regions or near them [16]. On the other 5 
hand, it has been stablished that SB transposase shows no predilection for transcription units, it 6 
rather preferentially recombines at intergenic chromosomal regions [57, 58]. In our study, a clear 7 
copy number-dependent fluorescence intensity was found in nine PB transgenic cell lines 8 
indicating that most transgenes landed in transcriptionally permissive chromatin domains 9 
allowing for a faithful transgene expression [59]. 10 
We have produced a total of 38 transgenic cloned bovine blastocysts using cells from PB and SB 11 
polyclonal lines as nuclear donor for SCNT. Developmental rates to blastocyst were not different 12 
for embryos reconstructed with PB or SB transgenic cells (36.0% vs 33.0%; respectively) and 13 
they are comparable to current standards of NT blastocyst development rates reached with non-14 
transgenic cells as nuclear donors [60-62]. Our nuclear transfer results reveal that transposon 15 
transgenic cells retain the ability to undergo nuclear reprograming to support early embryo 16 
development. Of the embryos that reached blastocyst stage, about half expressed the reporter 17 
fluorophore as per direct observation under blue light in an inverted microscope. We speculate 18 
that epigenetic silencing of transgene sequences could have occurred during initial cleavage 19 
divisions of the embryo. However, it cannot be ruled out that low-level reporter gene expression 20 
in some blastocysts was below the detection limit. Persistence of fluorophore expression without 21 
mosaicism in nuclear transfer blastocyst generated from cells transfected with PB plasmids was 22 















5. Conclusions 1 
In conclusion, both transposon systems under study were able to efficiently and precisely 2 
transpose monomeric copies of transgenes into bovine cell chromosomes. Transfection of 3 
primary bovine cell cultures with a helper-independent PB or the components of SB binary 4 
system notably increased (up to 88 times) the efficiency of genomic integration of foreign DNA 5 
molecules. Although donor cells are not normally considered a limiting resource for SCNT, 6 
improvements in stable gene integration in primary cells can be of value when working with 7 
difficult-to-transfect primary cells. Demonstrated multiplexing ability of SB is an asset when 8 
more complex genetic manipulations of the bovine genome are sought. These transposon-9 
transgenic cells can be reprogramed upon transfer to enucleated mature oocytes to 10 
morphologically normal blastocysts that expressed the transgene. Transposon-based transgenic 11 
methods alone or combined with other recombinase-based tools will simplify the production of 12 
transgenic cattle that consistently express the gene of interest. Incorporation of this active 13 
transgenesis method to the bovine transgenesis toolkit will certainly expand the opportunities for 14 
directed manipulation of the bovine genome for agricultural and biomedical applications. 15 
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Figure legends 1 
Fig. 1. Schematic representation of the experimental design. 2 
Fig. 2. Diagrams of the plasmid constructs used in the experiments showing the major 3 
components of each vector. 4 
Fig. 3. Microphotographs of fibroblast cells two days (a, b and c) and 16 days (d, e and f) after 5 
transfection with pmGENIE-2/∆piggyBac (a, d), pmGENIE-3 (b, e), or pmhyGENIE-3 (c, f) 6 
(Bars = 100 µm). After 14 days of antibiotic selection, discrete colonies of different sizes were 7 
evident (d, e and f). (g) Schematic representation of pmGENIE-3 plasmid showing position of 8 
three pair of primers (PB-TPase-F/PB-TPase-R, PB-ITR-F/PB-ITR-R and PB-GFP-F/PB-GFP-9 
R) used for PCR analysis of genomic DNA from pGENIE-3 (A1-A5) and pmhyGENIE-3 (B2, 10 
B3, B5 and B11) transgenic cell lines. A 187-bp fragment of EGFP gene (GFP) was amplified 11 
from gDNA from all transgenic cell lines and positive control, but it was not amplified from wild 12 
type gDNA and negative control (C-). A PCR product corresponding to a 537-pb fragment 13 
extending from the 3’-ITR into the backbone of the plasmid was present in B2, B3 and B5 and 14 
absent in A1, A2, A3 A4, A5 B11 and wild type samples. A 245 bp product generated from PB 15 
transposase sequence was present in cell lines A1, B2, B3 and B5. 16 
Fig. 4. Results of the colony formation assay obtained from cells transfected with PB (a) or SB 17 
transposon systems (b and c). Transposition activity was measured by counting EGFP- positive 18 
and hygromycin-resistant colonies after two-week selection period. (a) The colony counts assay 19 
was performed in triplicated and the data were expressed as mean of No. of hygromycin B 20 
resistant colonies ± SEM (n = 4-7). (b) Transposition activity in cultures transfected with 21 
different ratios of helper to donor plasmids was measured by counting Venus- positive colonies 22 















BFF cultures transfected with different ratios of helper to donor plasmids (pT2RMCEVenus and 1 
pT2/SV40-Neo) after two-week antibiotic selection. Different letters indicate statistically 2 
significant differences (p˂0.05). C: pBSII-ISceI-skA (control plasmid), S: pCMV(CAT)T7-3 
SB100X, V: pT2RMCEVenus, N: pT2/SV40-Neo. 4 
Fig. 5. (a) Schematic drawing that shows the possible fates of the transgene and the 5 
recircularized backbone after transposition for SB and PB transgenic systems. Position of 6 
primers RL-F and RL-R is depicted in the figure. (b) Agarose gel showing a product of 442 bp 7 
amplified from the PB religated vector backbone inserted into the genome of BFF line A1. PCRs 8 
with gDNA from the remaining cell lines generated no amplification product. A negative control 9 
(C-) was included. Alignment between the expected religated backbone sequence and the actual 10 
sequence obtained by Sanger sequencing of the purified PCR product is shown in b. Boxed is the 11 
reconstituted TTAA tetranuclotide generated after transposition. (c) Agarose gel showing a PCR 12 
product of 233 bp amplified from the SB religated vector backbone inserted into the genome of 4 13 
BFF lines (LM16, LM25, LM45 and LM82). Digestion of PCR product from LM82 with XhoI 14 
rendered the expected two products of 75 and 158 bp (d). Lane 1 non-digested PCR product, lane 15 
2 digested PCR product and lane 3 wild type control. 16 
Fig. 6. Number of copies of transgene as determined by RT-qPCR (a) and relationship between 17 
fluorescence intensity ( TCF) and transgene copy number. Linear regression demonstrated an 18 
association between the two variables (R2 = 0.93; p˂0.05). Cell lines A1-A5 correspond to cell 19 
















Fig. 7. Microphotographs of transient and stable expression of the Venus reporter, 2 days post-1 
transfection (a) 4 (b), 11 (c) and 15 days (d) after G418 antibiotic selection of BFF transfected 2 
with the SB plasmids. Note colony formation in c and d panels (Bar = 100 µm). (e) Schematic of 3 
pT2RMCEVenus and pCMV-SB100X plasmids showing the hybridization sites of SB-Venus, 4 
SB-ITR, SB-BB and SB-TPase pairs of primers used in PCRs. (f) PCR analysis of gDNA from 5 
six SB monoclonal cell lines. gDNA from all transgenic cell lines generated an expected PCR 6 
product of 280 bp corresponding to the Venus gene. A PCR product corresponding to a 408-bp 7 
fragment extending from the 3’-ITR into the backbone of the plasmid was present in LM16, 8 
LM27, LM82 and LM87 and absent in LM25, and LM45. None of the cell lines gDNAs 9 
generated a PCR product with primers SB-BB (amplification of part of plasmid backbone) or 10 
SB-TPase (amplification from pCMV(CAT)T7-SB100X). Positive control (C+) and negative 11 
controls (C-) were included. 12 
Fig. 8. Representative bright-field (a, b), fluorescent (d, e, g, h) microphotographs of blastocysts 13 
obtained by SCNT with PB (a, d, g) or SB (b, e, h) transgenic BFF (Bars = 100 µm). Transgenic 14 
blastocysts homogenously expressed reporter fluorophore in the inner cell mass and trophoblast 15 
cells (d, e). Vitrified/de-vitrified transgenic blastocysts were stained with Hoechst 33342 to 16 
determine cell numbers (e, f). Parthenogenic blastocyst (c) displayed negligible autofluorescence 17 
(f). 18 
Table Legend 19 
























Morulae (%) Blastocystsa (%) 
pmhyGENIE-3 124 108 (87.0) 43 (34.6) 41 (33.0) 23 (53.4) 23 (56.0) 
pT2RMCEVenus 75 66 (88.0) 29 (38.6) 27 (36.0) 15 (51.7) 15 (55.5) 
PA control 126 122 (96.8) 76 (60.3) 67 (53.1) - - 
n: number of reconstituted/fused presumptive embryos that were put in culture. Data from two independent 
replicates. PA: Parthenogenetic activation and in-vitro culture control. Tg+: Venus/EGFP expressing 
























































































































 PiggyBac (PB) and Sleeping Beauty (SB) transposons markedly enhanced transgene 
transfer into the bovine genome compared with the non-facilitated random 
integration based transgenic methods. 
 Both transposases (PB and SB) catalyzed integration of monomeric copies of the 
transgene into the bovine genome as determined by PCR based methods. 
 Use of SB transposon allows for simultaneously transposing two transgenes 
provided in separate donor plasmids (multiplex), useful when complex genetic 
manipulation are sought. 
 We determined number of transgene copies in monoclonal cell lines and found copy 
number-dependent fluorescence intensity, indicating faithful transgene expression. 
 Transposon-transgenic cells can be reprogramed upon transfer to enucleated mature 














Establishment of cell-based transposon-mediated transgenesis in cattle 
Alessio et al. 
Table 1. Primers name and sequences 

































Table 2 Bovine genomic insertion sites for PB transposons  
 
  
   Chromosome  Location  Gene  Sequence  
1  ch15  19428292  intergenic  cagactatctttctagggTTAACATATGAAC TGAGAGGG  
2  chrUn_JH122283  39105  unknown  cagactatctttctagggTTAAGGGATTTGAGTGAATTTG  
3  ch21  25472450  intergenic  cagactatctttctagggTTAAGACCCC ATGGACTGCAGC  
4  chrUn_AAFC03095622  1018  unknown  cagactatctttctagggTTAAGACCCCATGGACTGCAGC  
5  ch5  79123143  RBFOX2, intron  cagactatctttctagggTTAATCTCCTTTGCAGAAAGGA  
6  ch6  37957543  intergenic  cagactatctttctagggTTAAGGAGTTTAACAGGAATCA  
7  ch7  105149760  intergenic  cagactatctttctagggTTAAAGTCAGATCCACCAGTCT  
8  chrUn_JH121295  390708  unknown  cagactatctttctagggTTAATCTGAAGAAAAGTGAAAA  
9  ch15  141258670  intergenic  cagactatctttctagggTTAATGTACTGACAAAGCTCCA  
10  chX  529630  intergenic  cagactatctttctagggTTAAGACAAATGTGCTCTTAAA  
11  ch9  82826492  intergenic  cagactatctttctagggTTAAGCCACAAAAGCGGGGGTC  
12  ch26  18051846  intergenic  cagactatctttctagggTTAAAAAGGCAGTTTCCGCCAT  
13  ch2  8600480  GULP1, intron  cagactatctttctagggTTAAGATTAAGTGTGCCCCATC  
14  ch16  19235265  intergenic  cagactatctttctagggTTAAAAGATGTTGAATTAAGTT  
15  ch27  45374270  UBE2E2, intron  cagactatctttctagggTTAAAGATGAAAAATCCCCAGT  
16  ch27  10507265  intergenic  cagactatctttctagggTTAAAAAAGGTAGCCAGTTGCA  













Table 3 Bovine genomic insertion sites for SB transposon 
Insertion Chomos
ome 
Location Gene Sequence 
C5.1 13 78983 Prion Protein (PRNP) TTCTGTCATAAGGGTGGTGTCATATGCATACAGTTGAAGT 
C5.2 X 1 ZFX intron TCCCATGGGCCAAACACTGATCTAAGTATACAGTTGAAGT 
C5.4 25 3016 Sorting nexin 29 
(SNX29) 
CCCTGGTGGGGCGTATGCGGAAAGGAACTACAGTTGAAGT 
C5a.2 26 2080521 Intergenic  AANTGGCCAACAAAACAATATAGTGACCTACAGTTGAAGT 
C5a.5 12 27360511 Intergenic  TTTTTAGTGCAGGTTTGAGGGCTGGAATTACAGTTGAAGT 
C6.1 mtDNA 26009 Mitochondrial acetyl-
Coenzyme A 
acyltransferase 2 
(ACAA2), complete cds 
CTGACACTGTTTCCACTGTTTCCCCATCTACAGTTGAAGT 
C6a.3 19 44952926 Intergenic GCCAGGCTGGGAGGATCTGGACCATATACAGTTGAAGT 
C6a.5 25 36298502 Intergenic TGAATGGATAAAGAAAATATGGCATGTACAGTTGAAGT 
C7.2 13 35994 Intergenic GACACTGTTTCCACTGTTTCCCCATCTACAGTTGAAGT 
C7.3 22 24703993 Intergenic TTAAATAGATCTGAATTCTAAGCATTCATACAGTTGAAGT 
C7a.1 5 Unknown Intergenic TTTTAAGTGTTACATTTATTTCCAGCTACAGTTGAAGT 
C8a.2 18 Unknown Intergenic TTGATTACATAATGGATTATCTGGGATCTACAGTTGAAGT 
11.1 Y 465464 Y-linked ubiquitin-
specific protease 9 
(USP9Y) gene 
CTAAGGATTTTTAAAAATTAAATAAATATACAGTTGAAGT 
11.3 22 15535315 Intergenic GAACTGAAGTTGGAGAGACACAACTGTACAGTTGAAGT 
31.1 26 24931481 Intergenic AAGGATTTTTAAAAATTAAATAAATATACAGTTGAAGT 
 
 
